Literature DB >> 30245600

Corrigendum to "Erbium-Based Perfusion Contrast Agent for Small-Animal Microvessel Imaging".

Justin J Tse1,2, P Joy Dunmore-Buyze1, Maria Drangova1,2,3, David W Holdsworth1,4.   

Abstract

[This corrects the article DOI: 10.1155/2017/7368384.].

Entities:  

Year:  2018        PMID: 30245600      PMCID: PMC6126076          DOI: 10.1155/2018/2165693

Source DB:  PubMed          Journal:  Contrast Media Mol Imaging        ISSN: 1555-4309            Impact factor:   3.161


In the article titled “Erbium-Based Perfusion Contrast Agent for Small-Animal Microvessel Imaging” [1], there were errors in the scale bars in Figure 3, which should be corrected as follows:
Figure 3

Rebinned 100 μm voxel images where the (a) maximum intensity projection (MIP) of a whole body perfused mouse demonstrates that the attenuation of the Er2O3 contrast agent in the vasculature is higher than the mouse's skeletal structure. Quantitative measurements of attenuation (in HU) were obtained from regions drawn within heart (b), testes (c), inferior vena cava (d), and cortical bone (e).

  1 in total

1.  Erbium-Based Perfusion Contrast Agent for Small-Animal Microvessel Imaging.

Authors:  Justin J Tse; P Joy Dunmore-Buyze; Maria Drangova; David W Holdsworth
Journal:  Contrast Media Mol Imaging       Date:  2017-11-15       Impact factor: 3.161

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.